Skip to main content
Pharmaceutical Biology logoLink to Pharmaceutical Biology
. 2023 May 8;61(1):767. doi: 10.1080/13880209.2023.2210885

Correction

PMCID: PMC10167867  PMID: 37153987

Article title: Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway

Authors: Qi, X., Chen, Y., Liu, S., Liu, L., Yu, Z., Yin, L., Fu, L., Deng, M., Liang, S., & Lü, M.

Journal: Pharmaceutical Biology

Bibliometrics: Volume 61, Number 01, pages 696–709

DOI: https://doi.org/10.1080/13880209.2023.2200787

There were the below errors when this article first published online.

  1. In Figure 1(F), the pictures of A375 cells at 1.5 μM and 2 μM concentrations were repeated.

  2. In Figure 5(A), the images of A375 cells in the Control group at 0 h and at 1 μM concentration were repeated.

  3. In Figure 6(D), the images of A375 and A2058 cells at 1.5 μM and 2 μM concentrations were repeated.

  4. In Figure 9, the images of the Heart group at 2 mg/kg and 4 mg/ kg concentrations were repeated.

Figures 1, 5, 6, and 9 are now corrected and the article has been republished online.

Funding Statement

The author(s) reported there is no funding associated with the work featured in this article.


Articles from Pharmaceutical Biology are provided here courtesy of Taylor & Francis

RESOURCES